person · Reporting owner
McGuire Jonathan Will
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Flyte Aviation, Inc.RMED · Entity 8648 | Director · CEO & Secretary | November 20, 2022 | March 15, 2023 |
| Vivani Medical, Inc.EYES · Entity 6636 | Director | May 19, 2020 | May 20, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Flyte Aviation, Inc.
Report date November 20, 2022 · Filed March 15, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,083 |
Reported balance
After 2022-11-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-11-20 · Tax withholding · Disposed 84 · Balance 1,083 F1: Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock awards. This is not an open market sale of securities. F2: Reflects shares as a result of a reverse stock split. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock awards. This is not an open market sale of securities.
F2: Reflects shares as a result of a reverse stock split.
Vivani Medical, Inc.
Report date May 19, 2020 · Filed May 20, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 20,469 |
Reported balance
After 2020-05-19 transaction · row 1
1 source rowRow 1 · 2020-05-19 · Disposition to issuer · Disposed 3,357 · Balance 20,469 F1: Shares were sold under a rescission offer made to certain ESPP purchasers by the Company. The average price paid for the shares was determined by the original purchase price plus interest until the closing date of the repurchase. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were sold under a rescission offer made to certain ESPP purchasers by the Company. The average price paid for the shares was determined by the original purchase price plus interest until the closing date of the repurchase.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 20, 2022 Filed Mar 15, 2023 16:11 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | Tax withholdingCommon Stock | 84 | $2.67 | $224.28 |
DisclosureSEC source: 0001654954-23-002940 · section16.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · CEO & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,083 F1 · kind: Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock awards. This is not an open market sale of securities. F2 · balance_after: Reflects shares as a result of a reverse stock split. Read SEC document |
| May 20, 2022 Filed May 24, 2022 16:36 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | Tax withholdingCommon Stock | 4,241 | $0.30 | $1,277.81 |
DisclosureSEC source: 0001209191-22-031625 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,480 F1 · kind: Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock awards. This is not an open market sale of securities. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 16:02 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | SaleCommon Stock | 8,149 | $2.62 | $21,350.38 |
DisclosureSEC source: 0001209191-21-066773 · doc4.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,721 F2 · kind: Shares sold to satisfy the tax withholding requirement upon vesting of restricted stock awards. Read SEC document |
| November 20, 2021 Filed Nov 24, 2021 16:02 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | Disposition to issuerCommon Stock | 34,752 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-066773 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,870 F1 · kind: Represents forfeiture of shares underlying restricted stock award granted on November 17, 2020. Read SEC document |
| May 20, 2021 Filed May 24, 2021 18:08 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | Tax withholdingCommon Stock | 216 | $3.15 | $680.40 |
DisclosureSEC source: 0001209191-21-035493 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,622 F1 · kind: Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock awards. This is not an open market sale of securities. Read SEC document |
| November 20, 2020 Filed Nov 24, 2020 16:40 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | Tax withholdingCommon Stock | 216 | $6.39 | $1,380.24 |
DisclosureSEC source: 0001209191-20-060224 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,838 F1 · kind: Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock awards. This is not an open market sale of securities. Read SEC document |
| November 17, 2020 Filed Nov 19, 2020 16:33 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantCommon Stock | 104,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-059394 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,054 F1 · shares: The reported shares were issued as a restricted stock award ("RSA"). 50% of the shares underlying the RSA shall vest and become non-forfeitable as follows: 1/3 of the number of shares will vest on November 20, 2021, and 1/6th of the number of shares will vest on each May 20 and November 20 thereafter, such that 50% of the RSA will be fully vested on November 20, 2023; provided, however, that if a vesting date would otherwise fall on a day when the national stock exchange upon which the shares are listed is not open for trading, vesting will occur on the first trading day thereafter. The remaining 50% of the shares underlying the RSA shall vest and become non-forfeitable upon certain performance milestones being met by November 20, 2021. Vesting in all instances is subject to the reporting person's continuous status as a Service Provider (as defined in the 2018 Equity Incentive Plan) through each vesting date. F2 · balance_after: On November 16, 2020, the common stock of the company reverse-split 25-for-1, resulting in the reporting persons ownership being reduced by 139,200. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:17 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | PurchaseWarrants (right buy) · Derivative | 10,000 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001209191-20-045203 · doc4.xml · derivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2025-08-04 Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:17 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | PurchaseCommon Stock | 10,000 | $0.35 | $3,500.00 |
DisclosureSEC source: 0001209191-20-045203 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,000 Read SEC document |
| May 22, 2020 Filed May 27, 2020 17:14 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | PurchaseCommon Stock | 10,000 | $0.46 | $4,648.00 |
DisclosureSEC source: 0001209191-20-032343 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,000 Read SEC document |
| May 19, 2020 Filed May 20, 2020 00:29 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Disposition to issuerCommon Stock | 3,357 | $5.29 | $17,758.53 |
DisclosureSEC source: 0001209191-20-030770 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,469 F1 · shares: Shares were sold under a rescission offer made to certain ESPP purchasers by the Company. The average price paid for the shares was determined by the original purchase price plus interest until the closing date of the repurchase. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 17:56 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantStock Option (right to buy) · Derivative | 450,000 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001209191-20-022225 · doc4.xml · derivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2030-03-30 F2 · derivative.exercise_date: The option shall vest in equal monthly installments over four years following March 30, 2020, subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2020 Inducement Equity Incentive Plan) to the Company through each vesting date, so that the option is fully vested on March 30, 2024. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 17:56 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantCommon Stock | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-022225 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 F1 · shares: The reported shares were issued as a restricted stock award ("RSA"). The RSA shall vest and become non-forfeitable in equal semi-annual installments over four years following May 20, 2020, subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2020 Inducement Equity Incentive Plan) through each vesting date (for the avoidance of doubt, the first vesting date for the RSA will be November 20, 2020, upon which date 1/8 of the shares covered by the RSA may vest). Read SEC document |
| February 20, 2020 Filed Feb 21, 2020 22:28 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 1,793 | $5.44 | $9,753.92 |
DisclosureSEC source: 0001209191-20-011659 · doc4.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,826 F2 · shares: 1,793 shares were sold to satisfy the tax withholding obligations on vesting and release of common stock from RSUs. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:28 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 5,532 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011659 · doc4.xml · derivative · entry 3 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,593 Underlying: Common Stock · 22,125 shares Expires 2023-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The RSUs vest over four years, in equal annual installments, subject to continuous employment. Read SEC document |
| February 19, 2020 Filed Feb 21, 2020 22:28 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantCommon Stock | 5,532 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-011659 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,619 F1 · shares: 5,532 shares of common stock acquired upon vesting and release of common stock from restricted stock units (RSUs). Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 19:18 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantNon-Qualified Stock Option(right to buy) · Derivative | 43,755 | $0.00 Strike: $5.98 | $0.00 |
DisclosureSEC source: 0001209191-20-009544 · doc4.xml · derivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,755 Underlying: Common Stock · 43,755 shares Expires 2030-02-12 F1 · derivative.exercise_date: The stock options have a 10-year term and vest over four years from the grant date in equal monthly installments, subject to continuous employment, such that the total number shall be fully vested on the four-year anniversary of the transaction date. Read SEC document |
| August 20, 2019 Filed Aug 21, 2019 00:36 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 3,902 | $0.81 | $3,150.87 |
DisclosureSEC source: 0001209191-19-046916 · doc4.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,770 F2 · shares: 3,902 shares were sold to satisfy the tax withholding obligations on final vesting and release of common stock from RSUs. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 00:36 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 11,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-046916 · doc4.xml · derivative · entry 3 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,875 shares Expires 2019-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: RSUs were granted on 8/17/2015 and vest over a 4 year term, with 25% of the total number of units vesting on the first anniversary of the grant date and thereafter vesting in 12 equal quarterly installments of 6.25% of the total number of units. Read SEC document |
| August 19, 2019 Filed Aug 21, 2019 00:36 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionCommon Stock | 11,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-046916 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: 11,875 shares of common stock acquired upon final vesting and release of common stock from restricted stock units (RSUs). Read SEC document |
| May 21, 2019 Filed May 22, 2019 21:58 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 3,867 | $0.85 | $3,287.34 |
DisclosureSEC source: 0001209191-19-032148 · doc4.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,088 F2 · shares: 3,867 shares were sold to satisfy the tax withholding obligations on partial vesting and release of common stock from RSUs. Read SEC document |
| May 20, 2019 Filed May 22, 2019 21:58 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionResrticted Stock Units (RSUs) · Derivative | 11,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032148 · doc4.xml · derivative · entry 3 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,875 Underlying: Common Stock · 11,875 shares Expires 2019-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: RSUs were granted on 8/17/2015 and vest over a 4 year term, with 25% of the total number of units vesting on the first anniversary of the grant date and thereafter vesting in 12 equal quarterly installments of 6.25% of the total number of units. Read SEC document |
| May 20, 2019 Filed May 22, 2019 21:58 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionCommon Stock | 11,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032148 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: 11,875 shares of common stock acquired upon partial vesting and release of common stock from restricted stock units (RSUs). Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 21:48 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantWarrants to Purchase Common Stock · Derivative | 6,954 | Not disclosed Strike: $1.47 | Not disclosed |
DisclosureSEC source: 0001209191-19-013582 · doc4.xml · derivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,748 Underlying: Common Stock · 6,954 shares Expires 2024-03-14 F1 · shares: 6,954 shares of common stock and 6,954 warrants to purchase shares of common stock were acquired in a Rights Offering with the final allocation of shares confirmed on February 22, 2019. F2 · price: The common stock and warrants reported on this Form 4, were acquired upon exercise of subscription rights to purchase units previously distributed by the Issuer to holders of its common stock. Each unit consisted of one share of common stock and one warrant. The purchase price was $0.724 per unit. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 21:48 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantCommon Stock | 6,954 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-013582 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,080 F1 · shares: 6,954 shares of common stock and 6,954 warrants to purchase shares of common stock were acquired in a Rights Offering with the final allocation of shares confirmed on February 22, 2019. F2 · price: The common stock and warrants reported on this Form 4, were acquired upon exercise of subscription rights to purchase units previously distributed by the Issuer to holders of its common stock. Each unit consisted of one share of common stock and one warrant. The purchase price was $0.724 per unit. Read SEC document |
| February 20, 2019 Filed Feb 22, 2019 00:45 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 4,724 | $0.73 | $3,435.77 |
DisclosureSEC source: 0001209191-19-012321 · doc4.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,126 F2 · shares: 4,724 shares were sold to satisfy the tax withholding obligations on partial vesting and release of common stock from RSUs. Read SEC document |
| February 19, 2019 Filed Feb 22, 2019 00:45 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantRestricted Stock Units(RSUs) · Derivative | 177,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012321 · doc4.xml · derivative · entry 4 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,000 Underlying: Common Stock · 177,000 shares Expires not disclosed F4 · derivative.exercise_date: The RSUs will vest over four years, in equal annual installments, subject to continuous employment. F4 · derivative.expiration_date: The RSUs will vest over four years, in equal annual installments, subject to continuous employment. Read SEC document |
| February 19, 2019 Filed Feb 22, 2019 00:45 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantNon-Qualified Stock Option(right to buy) · Derivative | 354,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001209191-19-012321 · doc4.xml · derivative · entry 3 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,000 Underlying: Common Stock · 354,000 shares Expires 2029-02-19 F3 · derivative.exercise_date: The stock options have a 10-year term and vest over four years from the grant date in equal monthly installments, subject to continuous employment, such that the total number shall be fully vested on the four-year anniversary of the transaction date. Read SEC document |
| February 19, 2019 Filed Feb 22, 2019 00:45 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionCommon Stock | 11,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012321 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,850 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: 11,875 shares of common stock acquired upon partial vesting and release of common stock from restricted stock units (RSUs). Read SEC document |
| November 21, 2018 Filed Nov 22, 2018 01:44 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 3,920 | $1.16 | $4,547.20 |
DisclosureSEC source: 0001437749-18-021222 · rdgdoc.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,753 F2 · shares: 3,920 shares were sold to satisfy the tax withholding obligations on partial vesting and release of common stock from RSUs. Read SEC document |
| November 20, 2018 Filed Nov 22, 2018 01:44 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 11,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-021222 · rdgdoc.xml · derivative · entry 3 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,625 Underlying: Common Stock · 11,875 shares Expires 2019-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: RSUs were granted on 8/17/2015 and vest over a 4 year term, with 25% of the total number of units vesting on the first anniversary of the grant date and thereafter vesting in 12 equal quarterly installments of 6.25% of the total number of units. Read SEC document |
| November 20, 2018 Filed Nov 22, 2018 01:44 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionCommon Stock | 11,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-021222 · rdgdoc.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,673 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: 11,875 shares of common stock acquired upon partial vesting and release of common stock from restricted stock units (RSUs). Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 01:13 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 10,000 | $1.87 | $18,660.00 |
DisclosureSEC source: 0001437749-18-017854 · rdgdoc.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,798 F1 · shares: 10,000 shares were sold for tax planning purposes under a 10b5-1 plan dated 6/15/2018 by Mr. McGuire. F2 · price: Represents the weighted average sales price for the shares. The shares were sold at prices ranging from $1.86 per share to $1.90 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 22:34 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 10,000 | $1.68 | $16,750.00 |
DisclosureSEC source: 0001437749-18-016681 · rdgdoc.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,798 F1 · shares: 10,000 shares were sold for tax planning purposes under a 10b5-1 plan dated 6/15/2018 by Mr. McGuire. F2 · price: Represents the weighted average sales price for the shares. The shares were sold at prices ranging from $1.65 per share to $1.73 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 21, 2018 Filed Aug 22, 2018 19:24 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 3,777 | $1.60 | $6,043.20 |
DisclosureSEC source: 0001437749-18-016012 · rdgdoc.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,798 F2 · shares: 3,777 shares were sold to satisfy the tax withholding obligations on partial vesting and release of common stock from RSUs. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 19:24 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionRestricted Stock Units (RSUs) · Derivative | 11,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-016012 · rdgdoc.xml · derivative · entry 3 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,500 Underlying: Common Stock · 11,875 shares Expires 2019-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: RSUs were granted on 8/17/2015 and vest over a 4 year term, with 25% of the total number of units vesting on the first anniversary of the grant date and thereafter vesting in 12 equal quarterly installments of 6.25% of the total number of units. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 19:24 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionCommon Stock | 11,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-016012 · rdgdoc.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,575 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: 11,875 shares of common stock acquired upon partial vesting and release of common stock from restricted stock units (RSUs). Read SEC document |
| May 31, 2018 Filed Jun 2, 2018 00:29 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantCommon Stock | 10,582 | $1.16 | $12,232.79 |
DisclosureSEC source: 0001437749-18-011113 · rdgdoc.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,700 F1 · shares: Shares acquired under the 2015 Employee Stock Purchase Plan (ESPP) Read SEC document |
| May 21, 2018 Filed May 23, 2018 01:10 UTC | Vivani Medical, Inc. EYES · Entity 6636 | SaleCommon Stock | 3,755 | $2.18 | $8,185.90 |
DisclosureSEC source: 0001615774-18-004244 · s110375_form4.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,118 F2 · shares: 3,755 shares were sold to satisfy the tax withholding obligations on partial vesting and release of common stock from RSUs. Read SEC document |
| May 18, 2018 Filed May 23, 2018 01:10 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 11,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-004244 · s110375_form4.xml · derivative · entry 3 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,375 Underlying: Common Stock · 11,875 shares Expires 2019-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: RSUs were granted on 8/17/15 and vest over a 4 year term, with 25% of the total number of units vesting on the first anniversary of the grant date and thereafter vesting in 12 equal quarterly installments of 6.25% of the total number of units. Read SEC document |
| May 18, 2018 Filed May 23, 2018 01:10 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionCommon Stock | 11,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-18-004244 · s110375_form4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: 11,875 shares of common stock acquired upon partial vesting and release of common stock from restricted stock units (RSUs). Read SEC document |
| March 09, 2018 Filed Mar 12, 2018 23:41 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Disposition to issuerCommon Stock | 4,216 | $1.69 | $7,125.04 |
DisclosureSEC source: 0001615774-18-001836 · s109313_form4.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,998 F2 · balance_after: 4,216 shares were sold to satisfy the tax withholding requirements on vesting of RSUs. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 23:41 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 11,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001615774-18-001836 · s109313_form4.xml · derivative · entry 8 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,250 Underlying: Common Stock · 190,000 shares Expires 2019-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. F5 · price: Not Applicable. F3 · derivative.exercise_date: Options and RSUs vest over a 4 year term, with 25% vesting on the Date Exercisable as set forth in this Form 4 and thereafter vesting in 12 equal quarterly installments of 6.25%. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 23:41 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionCommon Stock | 11,875 | $1.73 | $20,543.75 |
DisclosureSEC source: 0001615774-18-001836 · s109313_form4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: 11,875 shares of common stock acquired upon quarterly vesting of Restricted Stock Units (RSUs). Read SEC document |
| February 19, 2018 Filed Feb 22, 2019 00:45 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionRestricted Stock Units(RSUs) · Derivative | 11,875 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-012321 · doc4.xml · derivative · entry 5 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,750 Underlying: Common Stock · 11,875 shares Expires 2019-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: RSUs were granted on 8/17/2015 and vest over a 4 year term, with 25% of the total number of units vesting on the first anniversary of the grant date and thereafter vesting in 12 equal quarterly installments of 6.25% of the total number of units. Read SEC document |
| January 04, 2018 Filed Jan 9, 2018 00:34 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 450,000 | Not disclosed Strike: $2.06 | Not disclosed |
DisclosureSEC source: 0001615774-18-000196 · s108662_form4.xml · derivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2028-01-04 F3 · price: Not Applicable F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable at a rate of 25% of the total number of shares on the one-year anniversary of January 4, 2018 (the "Vesting Commencement Date") and 6.25% of the total number of shares shall vest each quarterly anniversary of the Vesting Commencement Date thereafter, for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the four-year anniversary of the Vesting Commencement Date. Read SEC document |
| November 21, 2017 Filed Nov 22, 2017 18:45 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 11,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001615774-17-006962 · s108268_form4.xml · derivative · entry 7 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,125 Underlying: Common Stock · 190,000 shares Expires 2019-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. F5 · price: Not Applicable. F3 · derivative.exercise_date: Options and RSUs vest over a 4 year term, with 25% vesting on the Date Exercisable as set forth in this Form 4 and thereafter vesting in 12 equal quarterly installments of 6.25%. Read SEC document |
| November 21, 2017 Filed Nov 22, 2017 18:45 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Disposition to issuerCommon Stock | 4,522 | $1.18 | $5,335.96 |
DisclosureSEC source: 0001615774-17-006962 · s108268_form4.xml · nonDerivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,339 F2 · balance_after: 4,522 shares were sold to satisfy the tax withholding requirements on vesting of RSUs. Read SEC document |
| November 20, 2017 Filed Nov 22, 2017 18:45 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionCommon Stock | 11,875 | $1.19 | $14,131.25 |
DisclosureSEC source: 0001615774-17-006962 · s108268_form4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: 11,875 shares of common stock acquired upon quarterly vesting of Restricted Stock Units (RSUs). Read SEC document |
| August 30, 2017 Filed Aug 31, 2017 21:17 UTC | Vivani Medical, Inc. EYES · Entity 6636 | Exercise / conversionRestricted Stock Unit (RSU) · Derivative | 11,875 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001615774-17-004890 · s107388_form4.xml · derivative · entry 7 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 190,000 shares Expires 2019-08-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock of the Company. F5 · price: Not Applicable. F3 · derivative.exercise_date: Options and RSUs vest over a 4 year term, with 25% vesting on the Date Exercisable as set forth in this Form 4 and thereafter vesting in 12 equal quarterly installments of 6.25%. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.